A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency.

MLA

Pallet, Nicolas, et al. “A Comprehensive Population-Based Study Comparing the Phenotype and Genotype in a Pretherapeutic Screen of Dihydropyrimidine Dehydrogenase Deficiency.” British Journal of Cancer, vol. 123, no. 5, Sept. 2020, pp. 811–18. EBSCOhost, https://doi.org/10.1038/s41416-020-0962-z.

APA

Pallet, N., Hamdane, S., Garinet, S., Blons, H., Zaanan, A., Paillaud, E., Taieb, J., Laprevote, O., Loriot, M.-A., & Narjoz, C. (2020). A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency. British Journal of Cancer, 123(5), 811–818. https://doi.org/10.1038/s41416-020-0962-z

Chicago

Pallet, Nicolas, Salma Hamdane, Simon Garinet, Hélène Blons, Aziz Zaanan, Elena Paillaud, Julien Taieb, Olivier Laprevote, Marie-Anne Loriot, and Céline Narjoz. 2020. “A Comprehensive Population-Based Study Comparing the Phenotype and Genotype in a Pretherapeutic Screen of Dihydropyrimidine Dehydrogenase Deficiency.” British Journal of Cancer 123 (5): 811–18. doi:10.1038/s41416-020-0962-z.